Aarti Drugs looking to dazzleAarti drugs limited is a pharmaceutical & biotechnology company engaged in manufacturing of APIs (Active Pharmaceutical Ingredients), Pharma Intermediates & Specialty chemicals. With strong Research and Development (R&D) and GMP certified manufacturing units the company aims to provide quality and effective solutions to their clients PAN India.
CMP of the stock is 457.80. Negative of the company is declining annual net profit. Positives of the company are low debt, improving quarterly net profit and FIIs and MFs are increasing stake.
Entry in the stock can be taken after closing above 471. Target will be 512 & 531. Long term target will be 600+. Stop loss in the stock should be kept at the closing below 396.
